Journal article
Clinical Pharmacology and Therapeutics, vol. 111, 2022 Feb, pp. 435--443
APA
Click to copy
Zanussi, J. T., Zhao, J., Dorn, C. A., Liu, G., Feng, Q. P., Wei, W. Q., … Kawai, V. K. (2022). Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach. Clinical Pharmacology and Therapeutics, 111, 435–443.
Chicago/Turabian
Click to copy
Zanussi, Jacy T., Juan Zhao, Chad A. Dorn, Ge Liu, QiPing Feng, WeiQi Wei, Jonathan D. Mosley, C. Michael Stein, and Vivian K. Kawai. “Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach.” Clinical Pharmacology and Therapeutics 111 (February 2022): 435–443.
MLA
Click to copy
Zanussi, Jacy T., et al. “Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach.” Clinical Pharmacology and Therapeutics, vol. 111, Feb. 2022, pp. 435–43.
BibTeX Click to copy
@article{zanussi2022a,
title = {Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach},
year = {2022},
month = feb,
journal = {Clinical Pharmacology and Therapeutics},
pages = {435--443},
volume = {111},
author = {Zanussi, Jacy T. and Zhao, Juan and Dorn, Chad A. and Liu, Ge and Feng, QiPing and Wei, WeiQi and Mosley, Jonathan D. and Stein, C. Michael and Kawai, Vivian K.},
month_numeric = {2}
}